Mounjaro (tirzepatide) aids weight loss by acting on two hormones: GIP and GLP-1. This reduces appetite, slows digestion, and stabilises blood sugar. In clinical trials, patients lost up to 20.9% of their body weight over 72 weeks on the highest dose.
Keep reading to understand exactly how it works, what the data shows, and whether you might be eligible.
Table of Contents
What is Mounjaro (Tirzepatide)?
Mounjaro is a prescription medicine made by Eli Lilly. Its active ingredient is tirzepatide. This molecule mimics two natural gut hormones: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).
Tirzepatide is licensed in the UK by the MHRA for type 2 diabetes and separately for weight management. In the UK, the weight management product is Mounjaro. You may see it called Zepbound in American sources; that brand is not available here.
How Does Mounjaro Help With Weight Loss?
Mounjaro works on two fronts simultaneously. It signals the brain to reduce hunger while also slowing down how quickly the stomach processes food. These effects combine to cut calorie intake without requiring willpower alone.
Mounjaro Helps Reduce Appetite
Tirzepatide targets the hypothalamus, the part of the brain that regulates hunger. Activating satiety signals helps reduce what many patients call “food noise.” This is that constant background thinking about food, snacks, and the next meal.
Most people on Mounjaro report simply not feeling hungry the way they used to. Cravings become quieter, and the drive to eat between meals drops noticeably.
Mounjaro May Help You Feel Full for Longer
The drug influences the neural pathways connecting the gut to the brain. This means the fullness signal travels faster and stronger than it would without the medication.
Patients typically reach physical satiety after eating much smaller portions than before. Where someone might have finished a large meal, they now feel comfortably full partway through. That shift in portion tolerance alone drives meaningful calorie reduction over time.
Mounjaro Slows Gastric Emptying
Normally, the stomach clears food into the small intestine within 90 to 120 minutes. Mounjaro extends that process to roughly 4 to 5 hours. It is important to note that these effects on gastric emptying are greatest after the first dose and tend to diminish over time.
Food that stays longer in the stomach causes a feeling of fullness. This is a physical sensation, not just a hormonal signal. This is why patients stay satisfied well past the usual post-meal window.
Mounjaro Affects Blood Sugar and Insulin Regulation
Tirzepatide boosts insulin release only when blood sugar is high. This means it usually doesn’t lead to the dangerous lows seen with some older diabetes medications. However, there is an increased risk of hypoglycaemia if Mounjaro is used in combination with insulin or a sulfonylurea. At the same time, it lowers glucagon, the hormone that pushes the liver to release stored sugar.
The result is a more stable blood sugar environment throughout the day. Steady blood sugar all day leads to fewer spikes and crashes. This helps reduce cravings and makes it easier to eat less consistently.
How Much Weight Can You Lose on Mounjaro? (Clinical Trial Data)
The SURMOUNT-1 trial followed participants for 72 weeks. The results were significant across every dose tested:
| Dose | Average Body Weight Lost |
| 5 mg | 15.0% |
| 10 mg | 19.5% |
| 15 mg | 20.9% |
| Placebo | 3.1% |
More than half of participants on the 15 mg dose lost 20% or more of their total body weight. For someone weighing 100 kg, that is 20 kg lost over the course of the trial. These figures are consistently higher than what has been seen with GLP-1-only medications in comparable studies.
Does Mounjaro Suppress Hunger?
Yes, it does. The hunger suppression comes primarily through Mounjaro’s GLP-1 action on appetite centres in the brain. But there is a secondary effect worth understanding.
Mounjaro helps stop sharp blood sugar spikes and crashes after high-carb meals. This way, it reduces cravings for sugar and carbs. The cravings that often feel irresistible are frequently driven by these glucose swings. Flattening that curve takes away much of the biological urgency behind them.
Mounjaro Dosage and Injection Schedule
Mounjaro is given as a once-weekly subcutaneous injection, typically into the abdomen, thigh, or upper arm. The titration schedule is structured to minimise side effects as the body adjusts:
- Weeks 1 to 4: 2.5 mg weekly (starting dose to build tolerance)
- Every 4 weeks after: dose increases by 2.5 mg increments
- Maximum dose: 15 mg weekly
The gradual increase is intentional. Jumping straight to a high dose significantly raises the risk of gastrointestinal side effects. Most people reach their maintenance dose between the 5 mg, 10 mg, and 15 mg range; 5 mg is a legitimate maintenance endpoint for many patients. Treatment involves 4-week supply intervals with weekly contact during the titration phase. Clinicians will reassess continuation if at least 5% weight loss is not achieved after 6 months on the medication.
Mounjaro Side Effects
The most commonly reported side effects are gastrointestinal and tend to occur in the early weeks of treatment:
- Nausea (the most frequent complaint)
- Diarrhoea
- Constipation
- Indigestion
- Stomach pain or discomfort
These typically ease as the body adjusts to each new dose. Drinking enough water and eating smaller, low-fat meals can help many people adjust better.
Patients should know there’s a risk of pulmonary aspiration during general anesthesia or deep sedation. Delayed gastric emptying can increase the amount of stomach contents.
Rare but serious risks include pancreatitis and gallbladder disease. Anyone experiencing severe or persistent abdominal pain should contact their prescriber promptly.
Is Mounjaro Safe for Weight Loss?
Mounjaro is safe for weight management when a qualified clinician prescribes it and monitors use. However, it carries a black-box warning from regulatory authorities.
Mounjaro is contraindicated for individuals with a personal or family history of:
- Medullary Thyroid Carcinoma (MTC)
- Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)
Animal studies showed thyroid tumour development at high doses of tirzepatide. Whether this risk applies to humans at therapeutic doses is not yet fully established, which is why this warning exists. A thorough medical history is essential before prescribing.
Who May Be Eligible for Mounjaro for Weight Management?
Eligibility criteria generally follow the clinical thresholds used in the SURMOUNT trials and align with how Zepbound is approved in the US:
- Age 18-84
- Must have attempted supervised diet/lifestyle changes
- Type 2 diabetes must be diet-controlled
- BMI of 30 or above (classified as obesity), regardless of other conditions
- BMI of 27 or above (overweight) with at least one weight-related health condition, such as:
- High blood pressure
- Obstructive sleep apnoea
- Type 2 diabetes
- High cholesterol or cardiovascular disease risk
The treatment is strictly excluded for individuals with:
- Known eating disorders, pregnancy or breastfeeding
- History of pancreatitis or Type 1 diabetes
- Severe renal or hepatic impairment
- Crohn’s disease or significant gastroparesis
- Obesity secondary to endocrine disorders or medication
- Concurrent use of other GLP-1 or weight loss medications
These are firm criteria rather than guidelines. If you do not meet them, we cannot supply the treatment, though we can talk through other options. Your prescriber will look at your full medical history and current medications before suggesting Mounjaro.
Are Mounjaro, Ozempic and Wegovy the Same Drugs?
No. They share a category but are not the same.
Ozempic and Wegovy both contain semaglutide, a GLP-1 receptor agonist. They work on a single hormonal pathway. Wegovy is the higher-dose version of Ozempic, specifically licensed for weight loss.
Mounjaro contains tirzepatide, which is a dual agonist. It activates both GIP and GLP-1 receptors simultaneously. The extra GIP action is what makes tirzepatide different. It’s often seen as the reason why clinical data shows higher average weight loss percentages for tirzepatide compared to semaglutide in head-to-head studies.
Put simply, Mounjaro targets two hormones; Ozempic and Wegovy target one.
FAQs
Can you lose belly fat specifically with Mounjaro?
Mounjaro drives overall body fat reduction rather than targeting one area. Clinical data shows a high proportion of fat lost comes from visceral fat, the type stored around the abdomen and organs.
How quickly does Mounjaro start working for weight loss?
Most people notice appetite changes within the first one to two weeks. Weight loss usually starts between weeks four and eight. You’ll see the best results after several months of regular use.
Can Mounjaro be used long-term, or is it a short-term treatment?
Current evidence supports long-term use for ongoing weight management. Clinical trials like SURMOUNT-4 lasted up to 88 weeks. They found that weight often comes back if the medication stops and no lifestyle changes are made.
Does Mounjaro interact with other medications I might be taking?
Tirzepatide can affect oral medications. It slows absorption because it delays gastric emptying. Always share your complete medication list with your prescriber. This includes supplements and over-the-counter medicines.
One interaction matters more than the rest. If you take the pill, also use condoms or switch to a non-oral method. Do this for four weeks after you start and for four weeks after each dose increase.
Will I need to change my diet while taking Mounjaro?
No strict diet is required, but clinical guidance consistently recommends pairing Mounjaro with a balanced, reduced-calorie diet and regular physical activity to achieve and maintain the best outcomes.
Conclusion
Mounjaro works through a dual mechanism that no other weight loss drug currently matches in standard clinical use. It targets GIP and GLP-1 receptors. This reduces appetite in the brain and helps you feel full longer. It also stabilizes blood sugar, which helps control cravings. Clinical trial data support these findings. Weight loss results are consistently better than those from single-agonist treatments.
If you are considering Mounjaro, the right first step is speaking with a qualified healthcare provider. They can check your BMI, look at your medical history, and see if tirzepatide is right for your weight goals.
At Easy Pharmacy, our clinical team can guide you through eligibility and supply.
Dilip Modhvadia is the Co-Founder and Superintendent Pharmacist at Easy Pharmacy, with over 20 years of experience in community pharmacy. He holds an MPharm and is registered with the GPhC (Reg. No. 2050606). He leads Easy Pharmacy’s clinical services, providing professional, patient-focused care.